• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国人群中 Toll 样受体 2 和 5 的遗传变异、幽门螺杆菌感染与胃癌及其前体的风险。

Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population.

机构信息

Department of Cancer Epidemiology, Peking University Cancer Hospital & Institute, Beijing, China.

出版信息

Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2594-602. doi: 10.1158/1055-9965.EPI-11-0702. Epub 2011 Oct 12.

DOI:10.1158/1055-9965.EPI-11-0702
PMID:21994405
Abstract

BACKGROUND

Genetic polymorphisms of Toll-like receptors (TLR) may influence the outcome of Helicobacter pylori infection and play important roles in gastric carcinogenesis. To screen the genetic variants of TLR2 and TLR5, and evaluate their associations with gastric cancer (GC) and its precursors, a population-based study was conducted in Linqu County, Shandong Province, China.

METHODS

Genetic variants were identified by PCR-based denaturing high-performance liquid chromatography and PCR-restriction fragment length polymorphism analysis in 248 GC cases, 846 subjects with advanced gastric lesions including 350 dysplasia and 496 intestinal metaplasia, and 496 superficial gastritis/mild chronic atrophic gastritis controls.

RESULTS

Nine allelic variants each were detected within the promoter and exons of TLR2 and TLR5. Among those, TLR2 c. -196 to -174 del carriers (ins/del+del/del) showed a significantly decreased risk of GC (adjusted OR, 0.66; 95% CI: 0.48-0.90), whereas TLR5 rs5744174 C carriers (TC+CC) had an increased risk of GC (OR, 1.43; 95% CI: 1.03-1.97). Further analysis indicated an elevated risk of GC in subjects with the TLR5 rs5744174 TC+CC genotype and H. pylori infection (OR, 3.35; 95% CI: 2.13-5.26), and a significant interaction between rs5744174 and H. pylori infection was observed (OR, 2.15; 95% CI: 1.12-4.16).

CONCLUSION

These findings suggest that TLR2 c. -196 to -174 ins > del, TLR5 rs5744174 and interaction between rs5744174 and H. pylori infection were associated with the development of GC.

IMPACT

TLR2 and TLR5 polymorphisms may play important roles in the process of H. pylori-related gastric carcinogenesis.

摘要

背景

Toll 样受体(TLR)的遗传多态性可能影响幽门螺杆菌感染的结果,并在胃癌发生中发挥重要作用。为了筛选 TLR2 和 TLR5 的遗传变异,并评估其与胃癌(GC)及其前体的关系,在中国山东省临朐县进行了一项基于人群的研究。

方法

通过基于 PCR 的变性高效液相色谱和 PCR-限制性片段长度多态性分析,在 248 例 GC 病例、846 例进展期胃病变患者(包括 350 例发育不良和 496 例肠化生)和 496 例浅表性胃炎/轻度慢性萎缩性胃炎对照中鉴定遗传变异。

结果

在 TLR2 和 TLR5 的启动子和外显子中各检测到 9 种等位基因变异。其中,TLR2 c.-196 至-174del 携带者(ins/del+del/del)GC 的风险显著降低(调整后的 OR,0.66;95%CI:0.48-0.90),而 TLR5 rs5744174C 携带者(TC+CC)GC 的风险增加(OR,1.43;95%CI:1.03-1.97)。进一步分析表明,在携带 TLR5 rs5744174TC+CC 基因型和幽门螺杆菌感染的患者中,GC 的风险升高(OR,3.35;95%CI:2.13-5.26),并且观察到 rs5744174 与幽门螺杆菌感染之间存在显著的交互作用(OR,2.15;95%CI:1.12-4.16)。

结论

这些发现表明 TLR2 c.-196 至-174ins>del、TLR5 rs5744174 以及 rs5744174 与幽门螺杆菌感染之间的相互作用与 GC 的发生有关。

影响

TLR2 和 TLR5 多态性可能在幽门螺杆菌相关胃癌发生过程中发挥重要作用。

相似文献

1
Genetic variants of toll-like receptor 2 and 5, helicobacter pylori infection, and risk of gastric cancer and its precursors in a chinese population.中国人群中 Toll 样受体 2 和 5 的遗传变异、幽门螺杆菌感染与胃癌及其前体的风险。
Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2594-602. doi: 10.1158/1055-9965.EPI-11-0702. Epub 2011 Oct 12.
2
[The correlation between polymorphisms of Toll-like receptor 2 and Toll-like receptor 9 and susceptibility to gastric cancer].[Toll样受体2和Toll样受体9基因多态性与胃癌易感性的相关性]
Zhonghua Yu Fang Yi Xue Za Zhi. 2011 Jul;45(7):588-92.
3
Genetic variants in cyclooxygenase-2: Expression and risk of gastric cancer and its precursors in a Chinese population.环氧化酶-2基因变异:中国人群中胃癌及其癌前病变的表达与风险
Gastroenterology. 2006 Jun;130(7):1975-84. doi: 10.1053/j.gastro.2006.03.021.
4
Genetic polymorphisms in the Toll-like receptor signalling pathway in Helicobacter pylori infection and related gastric cancer.幽门螺杆菌感染及相关胃癌中Toll样受体信号通路的基因多态性
Hum Immunol. 2014 Aug;75(8):808-15. doi: 10.1016/j.humimm.2014.06.001. Epub 2014 Jun 11.
5
[Helicobacter pylori and the progression of gastric cancer: a 10-year cohort study].[幽门螺杆菌与胃癌进展:一项10年队列研究]
Zhonghua Yi Xue Za Zhi. 2005 Oct 19;85(39):2758-61.
6
Genetic variations of TLR5 gene interacted with Helicobacter pylori infection among carcinogenesis of gastric cancer.TLR5基因的遗传变异在胃癌致癌过程中与幽门螺杆菌感染相互作用。
Oncotarget. 2017 May 9;8(19):31016-31022. doi: 10.18632/oncotarget.16050.
7
Association between interleukin-1 gene polymorphisms and Helicobacter pylori infection in gastric carcinogenesis in a Chinese population.白细胞介素-1基因多态性与中国人群胃癌发生中幽门螺杆菌感染的关系。
J Gastroenterol Hepatol. 2007 Feb;22(2):234-9. doi: 10.1111/j.1440-1746.2006.04379.x.
8
Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori.胃癌细胞上的Toll样受体TLR4、TLR5和TLR9:对与幽门螺杆菌相互作用的启示
Int J Med Microbiol. 2005 Jun;295(3):179-85. doi: 10.1016/j.ijmm.2005.02.009.
9
Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.幽门螺杆菌感染介导的 RUNX3 甲基化的逐步累积导致胃癌的进展。
Cancer. 2012 Nov 15;118(22):5507-17. doi: 10.1002/cncr.27604. Epub 2012 May 10.
10
No associations of Toll-like receptor 2 (TLR2) -196 to -174del polymorphism with the risk of Helicobacter pylori seropositivity, gastric atrophy, and gastric cancer in Japanese.在日本人中,Toll 样受体 2(TLR2)-196 到-174del 多态性与幽门螺杆菌血清阳性、胃萎缩和胃癌的风险无关。
Gastric Cancer. 2010 Nov;13(4):251-7. doi: 10.1007/s10120-010-0567-y. Epub 2010 Dec 3.

引用本文的文献

1
Association between TLR 2 (rs3804099), TLR4 (rs4986790), and TLR 9 (rs187084) polymorphism and leukemia risk: a systematic review and meta-analysis.Toll样受体2(rs3804099)、Toll样受体4(rs4986790)和Toll样受体9(rs187084)基因多态性与白血病风险的关联:一项系统评价和荟萃分析
Immunol Res. 2025 Jan 16;73(1):35. doi: 10.1007/s12026-025-09592-y.
2
The immunopathogenesis of -induced gastric cancer: a narrative review.幽门螺杆菌诱导的胃癌的免疫发病机制:一项叙述性综述。 (注:原文中“-induced”前面应该有具体的致病因素,这里按照常规推测为“幽门螺杆菌(Helicobacter pylori)”,如果不是,请根据实际情况修改译文)
Front Microbiol. 2024 Jul 5;15:1395403. doi: 10.3389/fmicb.2024.1395403. eCollection 2024.
3
Common variants in toll-like receptor family genes and risk of gastric cancer: a systematic review and meta-analysis.
Toll样受体家族基因的常见变异与胃癌风险:一项系统评价和荟萃分析
Front Genet. 2023 Nov 28;14:1280051. doi: 10.3389/fgene.2023.1280051. eCollection 2023.
4
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Toll 样受体导向的人类癌症治疗干预:分子和免疫学观点。
Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023.
5
The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis.全球范围内幽门螺杆菌感染个体的胃癌患病率:系统评价和荟萃分析。
BMC Infect Dis. 2023 Aug 19;23(1):543. doi: 10.1186/s12879-023-08504-5.
6
Innate Immune Responses in Pediatric Patients with Gastritis-A Trademark of Infection or Chronic Inflammation?小儿胃炎患者的先天免疫反应——感染还是慢性炎症的特征?
Children (Basel). 2022 Jan 18;9(2):121. doi: 10.3390/children9020121.
7
in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes.在人类胃中:临床结果的不一致性及可能原因。
Front Microbiol. 2021 Aug 17;12:713955. doi: 10.3389/fmicb.2021.713955. eCollection 2021.
8
Determination of EPIYA motif in strains isolated from patients with digestive disorder.从消化系统疾病患者中分离出的菌株中EPIYA基序的测定。
Heliyon. 2020 Sep 23;6(9):e04971. doi: 10.1016/j.heliyon.2020.e04971. eCollection 2020 Sep.
9
Characterization and strong risk association of to polymorphism and and their influence on mRNA expression in gastric cancer.胃癌中 至 多态性以及 与 的特征、强风险关联及其对mRNA表达的影响。
World J Gastrointest Oncol. 2020 May 15;12(5):535-548. doi: 10.4251/wjgo.v12.i5.535.
10
Genetic polymorphism patterns suggest a genetic driven inflammatory response as pathogenesis in appendicitis.遗传多态性模式表明遗传驱动的炎症反应是阑尾炎的发病机制。
Int J Colorectal Dis. 2020 Feb;35(2):277-284. doi: 10.1007/s00384-019-03473-1. Epub 2019 Dec 16.